.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

DATSCAN Drug Profile

« Back to Dashboard
Datscan is a drug marketed by Ge Hlthcare Inc and is included in one NDA. It is available from one supplier.

The generic ingredient in DATSCAN is ioflupane i-123. One supplier is listed for this compound. Additional details are available on the ioflupane i-123 profile page.

Summary for Tradename: DATSCAN

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1

Pharmacology for Tradename: DATSCAN

Clinical Trials for: DATSCAN

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Hlthcare Inc
DATSCAN
ioflupane i-123
SOLUTION;INTRAVENOUS022454-001Jan 14, 2011RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: DATSCAN

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ge Hlthcare Inc
DATSCAN
ioflupane i-123
SOLUTION;INTRAVENOUS022454-001Jan 14, 20115,310,912<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc